Macro Dragon WK #38: US Inflation, US Infra Bill Discussions & US Debt Ceiling are key for the pre-FOMC wk ahead Macro Dragon WK #38: US Inflation, US Infra Bill Discussions & US Debt Ceiling are key for the pre-FOMC wk ahead Macro Dragon WK #38: US Inflation, US Infra Bill Discussions & US Debt Ceiling are key for the pre-FOMC wk ahead

Macro Dragon WK #38: US Inflation, US Infra Bill Discussions & US Debt Ceiling are key for the pre-FOMC wk ahead

Macro 8 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon WK #38: US Inflation, US Infra Bill Discussions & US Debt Ceiling are key for the pre-FOMC wk ahead


Top of Mind…

  • TGIM & welcome to WK #38 – Hope everyone had a brilliant wkd
  • Risk off in the US last wk was most likely linked to debt ceiling concerns, with a warning from US Treasurer Yellen that the treasury would run out of money by Oct if the debt ceiling was not raised.
    1. Its worth noting the deadline passed wks ago & the US Treasury has been operating under extraordinary measures

    2. Whilst the US debt ceiling debate tends to be cyclically & always ends up with an eventual extension – it once again shows the tribalism between the democrats & republicans

      • Back in 2013 with Obama in office, the debt ceiling debate went on for so long, that the US government had to shut down parts of its operations (National Parks, Museums, etc)

      • This was basically the date that the republicans turned what was a signature bipartisan process, to rolling the dice with the credit rating, faith, clarity of US government debt

      • The US government eventually got downgrade from a ratings agency, which ended up marking the low of the stress in the bond market

      • Its worth noting that the debt ceiling crisis of 2013 lasted from c. Jan to Oct 17 2013, yet republican approval got decimated.

      • KVP’s view is this time, its different. The zeitgeist of the average voter is of entitlement & for the government to do more. MMT has left the loonie house. And the average American voter, just has many other priorities than the US deficit in an economy that is still tackling Covid
    3. The probability of it not being resolved & the US defaulting on its debt is probably 0.01% I.e. not very high, its all politics & posturing around the other discussions on the plate

    4. The risk-off at S&P down -1.7% for the wk to 4458, is pretty mild considering we are still up +19% YTD. It worth noting the divergence in CH, HK & JP equities. With the Nikkei now up over 13% in the last 3wks alone
  • Biden’s move to make vaccines mandatory for government agencies & employees, as well as introducing fines & friction for business that have not taken up vaccination has caused the usual expected uproar. People have to understand, that you are entitled to your own ideology, as long as it does not negatively impact the rest of society. KVP did a Macro Dragon Reflections piece on this months ago, on the end-game of covid. People need to be protected from themselves.

    Macro Dragon Reflections: Is it enough of the Hammer & Dance Strategy & time to just step through the imperfect Covid-Gateway?

  • Biden’s initiative is actually very bullish & one can expect this to ripple across globally, as politicians & country leaders come to realize what a lot of their constituents already know – we have to learn to live with covid, its endemic, its not a pandemic whereby we will ever get the virus to zero. The 2nd, 3rd & 4th order consequences are way bigger, than a small minority of the population dying. This is not to dilute or discount families & people who have lost loved ones to the virus – but to point out, almost all doctors & epidemiologists out there, are only trained to think about saving lives (The very linear 1st order consequence).

  • A lot more people will die, as well as structurally underperform - from the restrictions & lockdowns – for years to come, than covid will ever kill (depression, suicide, lost years in education, business, work options). And yes, that will continue to be a structural drag & unintended consequence of a lot of governmental actions. The result? Even more fiscal & government support to come for decades – they will not be able to turn off the taps… not for long anyway.

  • So what’s the eventual pathway to the other side of Covid look like? It’s a pathway of everyone getting vaccinated to a +80% hurdle in society (in rich countries at least, EMs have to take it on the chin & move on – the masks actually delay the eventual herd immunity needed by most EMs), then we start measuring the deaths instead of the infections… i.e. it made sense to measure the infections pre-vaccine, yet post vaccinations, the true measure for concern is deaths, which have been proven to be magnificently reduced to sub 2%. Or to frame it differently someone unvaccinated is +10x more likely to be hospitalized & +11x more likely to die of Covid-19, than someone who is vaccinated.

  • This is not ideology, but simple risk-reward on a cost-benefit analysis folks (Western countries & western frameworks tend to confuse ideology from reality – i.e. America the home of the free? Tell that to a Texan woman who got raped & now cannot get an abortion).

  • Again – this is cost-benefit skew folks, not ideology. Just how we get to play in society by paying taxes & respecting the rule of law (all these are costs or investments), the benefits are (or should be) safety, health, shelter, freedom to work, live, study, play & move where you can in that society.

  • Week ahead is really all about US Inflation, US debt ceiling & cont. focus on the $3.5T US Infrastructure bill that has been kicking around in congress for several weeks now
    1. There should be a soft Sep 15 deadline to getting the terms of the bill squared off, with a hard deadline that the already agreed $500B needs to be greenlighted no later than Sep 29

    2. There is a debate about how much of the potential $3.5T is priced in, KVP’s view is not much… it looks like the mkt is potentially expecting at least +$2T… yet it’s also worth noting US earnings continue to be very strong

    3. So a passing of +$2T would be very bullish for risks (new highs in S&P, Tech & Cyclical names, as well as crypto), the fully $3.5T being passed is likely a small probability of 10% & would be mega bullish for stocks & bearish for bonds

      • In a case of the $3.5T, the SPX is almost certainly to get to 5,000 from the 4,458 -1.7% of last wk
    4. If for some reason none of the infra. Bill gets through, i.e. $0… that would likely shave anything from a min -3% to -5% on the S&P taking us to a potential -10% to -15% pullback… yet this is also likely a low probability 10%

    5. Key point here is the zeitgeist of the US population is the government should do more… & I think the smarter republicans will also realize that

  • US CPI for Aug is out on Tue & expected at 5.3%e 5.4%p YoY, +0.4%e +0.5%p MoM.
    1. Its worth noting the chart below that shows a high positive correlation between US PPI & CPI. US PPI came in last wk at +8.3%, this is ATH since the survey data from Nov 2010 (c. 11yrs)

    2. Its also worth noting that similar to Average Hourly Wages, we’ve had 5 consecutive months of inflation beats in the US

  • Other Things of Note:
    1. We also have inflation figures out of the UK-CA-EZ, as well as RS out of the US & UK

    2. Monthly growth numbers out of China are due, given that the Caixin PMIs are both in contraction, the deceleration of the
      Chinese economy is likely continuing. This is actually potentially bullish for CH & HK stocks, as it likely raises the probability & magnitude of accommodative policies from the government into year end 

    3. 2Q GDP figures out of NZ on Thu 1.1%e 1.6%p. RBNZ swear that they will be hiking at the next mtg on Oct 6, yet they blinked at the last Aug 18 meeting when they were expected to hike.

      Macro Dragon: RBNZ blinks as it keeps rates on hold at 0.25%, following the nation-wide lock-down announced on Tue over one covid-case in NZ

    4. Aussie jobs data also due on Thu, with a big contraction expected (-80.0k e +2.2k a) given the lock-down & restrictions around the delta variant that have been a big theme in their 3Q

    5. Apple lost the case again EPIC games, on keeping people out of its app store & taking a default +30% of revenue – According to our equity strategist Peter Garnry, this is likely going to be taken as a warning shot against all US tech platforms

      • Its worth noting the Apple monopoly app business model, is also probably one of the easiest cases to make against big tech (i.e. Amazon is going to be a lot trickier than say Google or Facebook)
    6. Inflation continue to spike & beat across the Emerging Markets, causing a lot of their central banks to surprise with hikes or better than expected hikes. Yet even in places like Norway or Germany, its running at +3.4% & +3.9%

    7. Whilst we are selling off aggressively on some of the China Tech names & the Hang Seng in general – its worth noting we have had 3 consecutive up wks across most China tech names (even with the brutal Thu sell-off, that saw names like Tencent down close to -9%), the HSI & the CSI-300

      • KVP would focus on the prices doing the talking, rather than bother with the ambiguous task of seeing if we’ve hit peak regulatory concern & uncertainty. One thing is for sure, the sentiment is still super bearish, poor & feels like maximum uncertainty

      • Its worth remembering that making a bottom or a top is a process…
    8. The Fed should be in blackout given next wk’s FOMC meeting

    9. RBA Lowe is set to speak on Tues 1045am (SGT/HKT)

    10. There are tons of elections in Sep, including:

    11. There are host of central banks for WK #39: With decisions out of the US, ID, BZ, TU, SA, NO, SW, PH, UK. A few notes from the meetings from next wk.

-The Fed is likely to be a wash, with the press conference focused on tapering structure & whether it’s still a 2021 affair (hint it will be clearer for the Fed post knowing where we sit on the $3.5T infra bill).

-Norges bank should be up for what the RBNZ could not, set the bell-curve by being the first G10 CB to hike rates. KVP still loving the long NOKSEK 0.9952 +0.98% – the easy move is to 1.03/1.04. We were 1.05/6 lvls pre Covid & the thesis is simply NO > SW in hawkishness & inflation.

-Turkey as always has tail-risk to a cut, despite rampant inflation, Core readings came in better than expected. And some comments from the central bank governor (the 3rd in sub 3yrs & an Erdogan man), may suggest that they could be looking to ease in 4Q from the current 19.0%

-Brazil should continue their hiking regime to 6.38%e 5.25%p, as inflation is still rampant at +9.7% & elections are due next year.

-

Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way

Namaste,
KVP

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.